MTD:NYE-Mettler-Toledo International Inc. (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 1383.47

Change

-9.78 (-0.70)%

Market Cap

USD 10.87B

Volume

0.06M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Mettler-Toledo International Inc is engaged in the supply of precision instruments and services. It is a provider of weighing instruments for use in laboratory, industrial and food retailing applications.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-17 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.57 (-0.21%)

USD 199.35B
IQV IQVIA Holdings Inc

+2.69 (+1.12%)

USD 43.52B
A Agilent Technologies Inc

+0.66 (+0.48%)

USD 39.94B
LH Laboratory Corporation of Amer..

+0.21 (+0.09%)

USD 18.96B
DGX Quest Diagnostics Incorporated

+0.10 (+0.06%)

USD 17.18B
CRL Charles River Laboratories

-0.11 (-0.05%)

USD 10.65B
QGEN Qiagen NV

+0.02 (+0.04%)

USD 10.30B
VNRX Volitionrx Ltd

-0.05 (-7.58%)

USD 0.06B
ENZ Enzo Biochem Inc

-0.01 (-0.89%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

-0.37 (-0.06%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.19 (-0.79%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

-0.10 (-0.79%)

N/A
BMED BlackRock Future Health E.. 2.35 % 0.00 %

+0.08 (+-0.79%)

USD 4.21M
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

+0.29 (+-0.79%)

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

-0.09 (-0.79%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

-0.08 (-0.79%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

N/A

N/A
HECO 0.00 % 0.95 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-0.31 (-0.79%)

USD 7.64B
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

+0.17 (+-0.79%)

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

+0.14 (+-0.79%)

CAD 0.27B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.06% 85% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.06% 77% C+ 65% D
Trailing 12 Months  
Capital Gain 22.22% 85% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.22% 85% B 66% D+
Trailing 5 Years  
Capital Gain 94.83% 92% A 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 94.83% 92% A 83% B
Average Annual (5 Year Horizon)  
Capital Gain 16.79% 92% A 80% B-
Dividend Return 16.79% 92% A 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.88% 38% F 33% F
Risk Adjusted Return 54.37% 85% B 72% C
Market Capitalization 10.87B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 30.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.